Thomson Micromedex Partners WIth Logical Images To Offer Visual Diagnostic Software

GREENWOOD VILLAGE, 09/21/2005
Thomson Micromedex today announced a strategic partnership with Logical Images to provide hospitals and other healthcare organizations with access to VisualDx®, a point-of-care clinical decision support software system for visual diagnosis. Micromedex is a part of The Thomson Corporation (NYSE: TOC; TSX: TOC), a leader in enterprise-wide clinical knowledge solutions for scientific and healthcare professionals. Logical Images is a proprietary diagnostic software provider based in Rochester, N.Y.

VisualDx is an intuitive and easy to use visual differential diagnostic tool that minimizes the potential for medical error concerning conditions with visual signs and symptoms. The application is used at the point of care to make more accurate diagnoses, yielding faster and better treatment decisions and improved clinical outcomes.

“Complementing our proven disease continuum of care products, VisualDx helps clinicians in hospitals, emergency rooms, government agencies, and other organizations make better decisions, ultimately reducing costs and improving outcomes and safety—including potential bio-terrorist acts,” said Jay Katzen, vice president of marketing and product development, Thomson Micromedex.

Many primary care and emergency physicians lack training in visual diagnosis, dermatology and infectious disease. Until now, it has been necessary for clinicians to know the name of the diagnosis in order to access photographs, symptomology, and treatment information using textbooks and Web-based atlases. With VisualDx, clinicians simply enter a patient’s symptoms and compare what they are seeing with the system’s images and data on each disease similar to that found in reference books and other information guides.

In addition, VisualDx is an essential tool for early detection and treatment of conditions caused by chemical, biological, and radiological substances. The application is a front-line diagnostic solution enabling institutions to meet bioterrorism preparedness mandates for early detection and treatment as set by the U.S. Department of Health Resources and Services Administration (HRSA) and Centers for Disease Control and Prevention (CDC). VisualDx can be purchased with preparedness funding from those programs.

“For more than 30 years clinicians have depended on Micromedex for proven clinical knowledge solutions to help them make better treatment decisions, and we are delighted to team with this pioneering industry leader to add to their existing solutions,” said Michael O’Connor, president of Logical Images.

About Logical Images
Logical Images develops and markets proprietary point-of-care visual diagnostic software that enables health care providers to accurately diagnose and treat infectious diseases, agents of bioterrorism, drug eruptions, immunocompromised and oral lesions, and a wide range of common ailments and medical conditions. The company’s flagship product, VisualDx®, represents an expansive set of tools that merge the world’s largest collection of digitized images of medical conditions with rich textual information and provides a unique patient-centric approach to accessing relevant information. Logical Images is a global company with headquarters in Rochester, New York. For more information, visit www.logicalimages.com.

About The Thomson Corporation and Thomson Micromedex
The Thomson Corporation (www.thomson.com), with 2004 revenues of $8.10 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of scientific research, healthcare, law, tax, accounting, financial services, higher education, reference information, and corporate e-learning and assessment. Thomson Micromedex (www.micromedex.com), a part of Thomson Scientific & Healthcare, is the premier global provider of integrated clinical knowledge solutions that are delivered to clinicians whenever and wherever needed. Thomson, with operational headquarters in Stamford, Conn., has approximately 40,000 employees and provides services in approximately 130 countries. The Corporation’s common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Contact Information

Angela Jenkins

Media Contact

Thomson Micromedex

Contact via E-mail